GAO Says Govt. Doesn’t Own Patent Rights To Remdesivir

By John Wilkerson / April 8, 2021 at 10:00 AM
The Government Accountability Office said the U.S. government doesn’t own patent rights to Gilead’s remdesivir, a coronavirus treatment for which HHS Secretary Xavier Becerra last year urged the government to break the patent when he was California attorney general. Gilead patented remdesivir before government agencies began researching the compound, and research funded by the government did not result in inventions, GAO reported Wednesday (March 31). “Gilead entered research collaborations with federal agencies and universities with a portfolio of existing patents...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.